Modification of the behavioral effects of morphine in rats by serotonin (5-HT)1A and 5-HT2A receptor agonists: antinociception, drug discrimination, and ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-09-20

AUTHORS

Jun-Xu Li, Aparna P. Shah, Sunny K. Patel, Kenner C. Rice, Charles P. France

ABSTRACT

RationaleIndirect-acting serotonin (5-HT) receptor agonists can enhance the antinociceptive effects of morphine; however, the specific 5-HT receptor subtype(s) mediating this enhancement is not established.ObjectiveThis study examined interactions between morphine and both 5-HT1A and 5-HT2A receptor agonists in rats using measures of antinociception (radiant heat tail flick and warm water tail withdrawal), drug discrimination (3.2 mg/kg morphine versus saline), and locomotion.MethodsMale Sprague–Dawley rats (n = 7-8 per group) were used to examine the effects of morphine alone and in combination with DOM (5-HT2A agonist) and 8-OH-DPAT (5-HT1A agonist).ResultsDOM did not modify antinociceptive or discriminative stimulus effects while modestly attenuating locomotor-stimulating effects of morphine; the effect of DOM (0.32 mg/kg) on morphine-induced locomotion was prevented by the 5-HT2A receptor-selective antagonist MDL 100907. In contrast, 8-OH-DPAT (0.032–0.32 mg/kg) fully attenuated the antinociceptive effects (both procedures), did not modify the discriminative stimulus effects, and enhanced (0.32 mg/kg) the locomotor-stimulating effects of morphine. These effects of 8-OH-DPAT were prevented by the 5-HT1A receptor-selective antagonist WAY100635.ConclusionAgonists acting at 5-HT1A or 5-HT2A receptors do not modify all effects of mu opioid receptor agonists in a similar manner. Moreover, interactions between 5-HT and opioid receptor agonists vary significantly between rats and nonhuman primates, underscoring the value of comparing drug interactions across a broad range of conditions and in multiple species. More... »

PAGES

791-801

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00213-012-2870-2

DOI

http://dx.doi.org/10.1007/s00213-012-2870-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1000075998

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22993050


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Analgesics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Discrimination, Psychological", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Morphine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Motor Activity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pain", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pain Measurement", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Sprague-Dawley", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptor, Serotonin, 5-HT1A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptor, Serotonin, 5-HT2A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Serotonin 5-HT1 Receptor Agonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Serotonin 5-HT2 Receptor Agonists", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology and Toxicology, University at Buffalo, The State University of New York, Buffalo, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.273335.3", 
          "name": [
            "Department of Pharmacology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, 78229-3900, San Antonio, TX, USA", 
            "Department of Pharmacology and Toxicology, University at Buffalo, The State University of New York, Buffalo, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Jun-Xu", 
        "id": "sg:person.01324156236.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324156236.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, 78229-3900, San Antonio, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.267309.9", 
          "name": [
            "Department of Pharmacology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, 78229-3900, San Antonio, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shah", 
        "givenName": "Aparna P.", 
        "id": "sg:person.01365667754.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365667754.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, 78229-3900, San Antonio, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.267309.9", 
          "name": [
            "Department of Pharmacology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, 78229-3900, San Antonio, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Patel", 
        "givenName": "Sunny K.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chemical Biology Research Laboratory, Department of Health and Human Services, National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health (NIH), Bethesda, MD, USA", 
          "id": "http://www.grid.ac/institutes/grid.94365.3d", 
          "name": [
            "Chemical Biology Research Laboratory, Department of Health and Human Services, National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health (NIH), Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rice", 
        "givenName": "Kenner C.", 
        "id": "sg:person.0653222230.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653222230.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.267309.9", 
          "name": [
            "Department of Pharmacology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, 78229-3900, San Antonio, TX, USA", 
            "Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "France", 
        "givenName": "Charles P.", 
        "id": "sg:person.0651327113.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651327113.82"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00213-006-0490-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046544890", 
          "https://doi.org/10.1007/s00213-006-0490-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002130050490", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029185836", 
          "https://doi.org/10.1007/s002130050490"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00435276", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023910507", 
          "https://doi.org/10.1007/bf00435276"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00210-005-1036-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009091746", 
          "https://doi.org/10.1007/s00210-005-1036-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/npp.2010.232", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004824333", 
          "https://doi.org/10.1038/npp.2010.232"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002130000374", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021502037", 
          "https://doi.org/10.1007/s002130000374"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-09-20", 
    "datePublishedReg": "2012-09-20", 
    "description": "RationaleIndirect-acting serotonin (5-HT) receptor agonists can enhance the antinociceptive effects of morphine; however, the specific 5-HT receptor subtype(s) mediating this enhancement is not established.ObjectiveThis study examined interactions between morphine and both 5-HT1A and 5-HT2A receptor agonists in rats using measures of antinociception (radiant heat tail flick and warm water tail withdrawal), drug discrimination (3.2\u00a0mg/kg morphine versus saline), and locomotion.MethodsMale Sprague\u2013Dawley rats (n\u2009=\u20097-8 per group) were used to examine the effects of morphine alone and in combination with DOM (5-HT2A agonist) and 8-OH-DPAT (5-HT1A agonist).ResultsDOM did not modify antinociceptive or discriminative stimulus effects while modestly attenuating locomotor-stimulating effects of morphine; the effect of DOM (0.32\u00a0mg/kg) on morphine-induced locomotion was prevented by the 5-HT2A receptor-selective antagonist MDL 100907. In contrast, 8-OH-DPAT (0.032\u20130.32\u00a0mg/kg) fully attenuated the antinociceptive effects (both procedures), did not modify the discriminative stimulus effects, and enhanced (0.32\u00a0mg/kg) the locomotor-stimulating effects of morphine. These effects of 8-OH-DPAT were prevented by the 5-HT1A receptor-selective antagonist WAY100635.ConclusionAgonists acting at 5-HT1A or 5-HT2A receptors do not modify all effects of mu opioid receptor agonists in a similar manner. Moreover, interactions between 5-HT and opioid receptor agonists vary significantly between rats and nonhuman primates, underscoring the value of comparing drug interactions across a broad range of conditions and in multiple species.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00213-012-2870-2", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2483189", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2408119", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2724545", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1085440", 
        "issn": [
          "0033-3158", 
          "1432-2072"
        ], 
        "name": "Psychopharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "225"
      }
    ], 
    "keywords": [
      "locomotor-stimulating effects", 
      "opioid receptor agonists", 
      "receptor agonist", 
      "antinociceptive effect", 
      "stimulus effects", 
      "drug discrimination", 
      "mu-opioid receptor agonist", 
      "measures of antinociception", 
      "morphine-induced locomotion", 
      "effects of morphine", 
      "serotonin receptor agonist", 
      "discriminative stimulus effects", 
      "MethodsMale Sprague-Dawley", 
      "MDL 100907", 
      "drug interactions", 
      "Sprague-Dawley", 
      "morphine", 
      "locomotor activity", 
      "agonists", 
      "DPAT", 
      "behavioral effects", 
      "nonhuman primates", 
      "rats", 
      "antinociception", 
      "receptors", 
      "serotonin", 
      "effect", 
      "effects of DOM", 
      "locomotion", 
      "similar manner", 
      "primates", 
      "activity", 
      "discrimination", 
      "study", 
      "measures", 
      "contrast", 
      "broad range", 
      "manner", 
      "combination", 
      "multiple species", 
      "interaction", 
      "modification", 
      "values", 
      "enhancement", 
      "conditions", 
      "range", 
      "species", 
      "DOM"
    ], 
    "name": "Modification of the behavioral effects of morphine in rats by serotonin (5-HT)1A and 5-HT2A receptor agonists: antinociception, drug discrimination, and locomotor activity", 
    "pagination": "791-801", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1000075998"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00213-012-2870-2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22993050"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00213-012-2870-2", 
      "https://app.dimensions.ai/details/publication/pub.1000075998"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_565.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00213-012-2870-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00213-012-2870-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00213-012-2870-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00213-012-2870-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00213-012-2870-2'


 

This table displays all metadata directly associated to this object as RDF triples.

235 TRIPLES      21 PREDICATES      94 URIs      80 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00213-012-2870-2 schema:about N00a5ec5984b44868ae0ac274987a6a37
2 N09a74db574fc4a9fa0d7f93ffea90b97
3 N12ceadc3128f44369962f2d8b35f720c
4 N34ac9cc8a71a46469177b5550d3e82e8
5 N607f68e13b8c41888ca6d396c6a3a6dd
6 N6c651a2f091446d9bce1149e0a7ebdf6
7 N70bed415963345298d3645a89c5530d6
8 N7912b4b64fcd44938e6ebd004184820e
9 N86caaaccf7564d878c5f0f1a9f9968e6
10 N920e8c8c723d4bd5ae9e05a2e09ffc7b
11 N9a3698b845134f6fa8957799e367585e
12 Na76f5bb82d2f40de8edeae5ca47989a0
13 Ndaac303055984a81baa5019f771b6773
14 Ne23170b5f7194a04bee1d3e88ec13761
15 Nef6e0c4aa95d4dbea6299b15726400b0
16 anzsrc-for:11
17 anzsrc-for:1115
18 schema:author N549f268b814e4b97af92991180daa0c6
19 schema:citation sg:pub.10.1007/bf00435276
20 sg:pub.10.1007/s00210-005-1036-8
21 sg:pub.10.1007/s00213-006-0490-4
22 sg:pub.10.1007/s002130000374
23 sg:pub.10.1007/s002130050490
24 sg:pub.10.1038/npp.2010.232
25 schema:datePublished 2012-09-20
26 schema:datePublishedReg 2012-09-20
27 schema:description RationaleIndirect-acting serotonin (5-HT) receptor agonists can enhance the antinociceptive effects of morphine; however, the specific 5-HT receptor subtype(s) mediating this enhancement is not established.ObjectiveThis study examined interactions between morphine and both 5-HT1A and 5-HT2A receptor agonists in rats using measures of antinociception (radiant heat tail flick and warm water tail withdrawal), drug discrimination (3.2 mg/kg morphine versus saline), and locomotion.MethodsMale Sprague–Dawley rats (n = 7-8 per group) were used to examine the effects of morphine alone and in combination with DOM (5-HT2A agonist) and 8-OH-DPAT (5-HT1A agonist).ResultsDOM did not modify antinociceptive or discriminative stimulus effects while modestly attenuating locomotor-stimulating effects of morphine; the effect of DOM (0.32 mg/kg) on morphine-induced locomotion was prevented by the 5-HT2A receptor-selective antagonist MDL 100907. In contrast, 8-OH-DPAT (0.032–0.32 mg/kg) fully attenuated the antinociceptive effects (both procedures), did not modify the discriminative stimulus effects, and enhanced (0.32 mg/kg) the locomotor-stimulating effects of morphine. These effects of 8-OH-DPAT were prevented by the 5-HT1A receptor-selective antagonist WAY100635.ConclusionAgonists acting at 5-HT1A or 5-HT2A receptors do not modify all effects of mu opioid receptor agonists in a similar manner. Moreover, interactions between 5-HT and opioid receptor agonists vary significantly between rats and nonhuman primates, underscoring the value of comparing drug interactions across a broad range of conditions and in multiple species.
28 schema:genre article
29 schema:isAccessibleForFree true
30 schema:isPartOf Na2b8c1f03a734a32871d3e519ef6da2a
31 Nd06ec0b5914648b2a5758f9bf6c0e6ad
32 sg:journal.1085440
33 schema:keywords DOM
34 DPAT
35 MDL 100907
36 MethodsMale Sprague-Dawley
37 Sprague-Dawley
38 activity
39 agonists
40 antinociception
41 antinociceptive effect
42 behavioral effects
43 broad range
44 combination
45 conditions
46 contrast
47 discrimination
48 discriminative stimulus effects
49 drug discrimination
50 drug interactions
51 effect
52 effects of DOM
53 effects of morphine
54 enhancement
55 interaction
56 locomotion
57 locomotor activity
58 locomotor-stimulating effects
59 manner
60 measures
61 measures of antinociception
62 modification
63 morphine
64 morphine-induced locomotion
65 mu-opioid receptor agonist
66 multiple species
67 nonhuman primates
68 opioid receptor agonists
69 primates
70 range
71 rats
72 receptor agonist
73 receptors
74 serotonin
75 serotonin receptor agonist
76 similar manner
77 species
78 stimulus effects
79 study
80 values
81 schema:name Modification of the behavioral effects of morphine in rats by serotonin (5-HT)1A and 5-HT2A receptor agonists: antinociception, drug discrimination, and locomotor activity
82 schema:pagination 791-801
83 schema:productId N3ac3af276d1e479f924c7a7c958e2ba3
84 Nadffa4f974f141dda7ea27fe86a93789
85 Nb613e5196fec4294896ebb4a3ec29851
86 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000075998
87 https://doi.org/10.1007/s00213-012-2870-2
88 schema:sdDatePublished 2022-09-02T15:55
89 schema:sdLicense https://scigraph.springernature.com/explorer/license/
90 schema:sdPublisher N86a58a7077c742a091e5b920dfbe7928
91 schema:url https://doi.org/10.1007/s00213-012-2870-2
92 sgo:license sg:explorer/license/
93 sgo:sdDataset articles
94 rdf:type schema:ScholarlyArticle
95 N00a5ec5984b44868ae0ac274987a6a37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Receptor, Serotonin, 5-HT1A
97 rdf:type schema:DefinedTerm
98 N09a74db574fc4a9fa0d7f93ffea90b97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Serotonin 5-HT2 Receptor Agonists
100 rdf:type schema:DefinedTerm
101 N12ceadc3128f44369962f2d8b35f720c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Pain
103 rdf:type schema:DefinedTerm
104 N34ac9cc8a71a46469177b5550d3e82e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Motor Activity
106 rdf:type schema:DefinedTerm
107 N3ac3af276d1e479f924c7a7c958e2ba3 schema:name doi
108 schema:value 10.1007/s00213-012-2870-2
109 rdf:type schema:PropertyValue
110 N53d81e23b8ae4ef5931f6b8a2585d1ce rdf:first sg:person.01365667754.78
111 rdf:rest Nb3129bb566eb4a3cbd92a04bf7f4ae1e
112 N549f268b814e4b97af92991180daa0c6 rdf:first sg:person.01324156236.77
113 rdf:rest N53d81e23b8ae4ef5931f6b8a2585d1ce
114 N607f68e13b8c41888ca6d396c6a3a6dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Rats, Sprague-Dawley
116 rdf:type schema:DefinedTerm
117 N6c651a2f091446d9bce1149e0a7ebdf6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Discrimination, Psychological
119 rdf:type schema:DefinedTerm
120 N70bed415963345298d3645a89c5530d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Analgesics
122 rdf:type schema:DefinedTerm
123 N7912b4b64fcd44938e6ebd004184820e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Morphine
125 rdf:type schema:DefinedTerm
126 N823bcc090aa245cda03ae43b9f23b1ee rdf:first sg:person.0653222230.72
127 rdf:rest Ned1f94313c954055b2b9174213563a0e
128 N86a58a7077c742a091e5b920dfbe7928 schema:name Springer Nature - SN SciGraph project
129 rdf:type schema:Organization
130 N86caaaccf7564d878c5f0f1a9f9968e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Receptor, Serotonin, 5-HT2A
132 rdf:type schema:DefinedTerm
133 N920e8c8c723d4bd5ae9e05a2e09ffc7b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Animals
135 rdf:type schema:DefinedTerm
136 N9a3698b845134f6fa8957799e367585e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Pain Measurement
138 rdf:type schema:DefinedTerm
139 Na2b8c1f03a734a32871d3e519ef6da2a schema:issueNumber 4
140 rdf:type schema:PublicationIssue
141 Na76f5bb82d2f40de8edeae5ca47989a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Serotonin 5-HT1 Receptor Agonists
143 rdf:type schema:DefinedTerm
144 Nadffa4f974f141dda7ea27fe86a93789 schema:name pubmed_id
145 schema:value 22993050
146 rdf:type schema:PropertyValue
147 Nb3129bb566eb4a3cbd92a04bf7f4ae1e rdf:first Nf3d2191b51b84a76b4ad9f6886cc8ec9
148 rdf:rest N823bcc090aa245cda03ae43b9f23b1ee
149 Nb613e5196fec4294896ebb4a3ec29851 schema:name dimensions_id
150 schema:value pub.1000075998
151 rdf:type schema:PropertyValue
152 Nd06ec0b5914648b2a5758f9bf6c0e6ad schema:volumeNumber 225
153 rdf:type schema:PublicationVolume
154 Ndaac303055984a81baa5019f771b6773 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Dose-Response Relationship, Drug
156 rdf:type schema:DefinedTerm
157 Ne23170b5f7194a04bee1d3e88ec13761 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Male
159 rdf:type schema:DefinedTerm
160 Ned1f94313c954055b2b9174213563a0e rdf:first sg:person.0651327113.82
161 rdf:rest rdf:nil
162 Nef6e0c4aa95d4dbea6299b15726400b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Rats
164 rdf:type schema:DefinedTerm
165 Nf3d2191b51b84a76b4ad9f6886cc8ec9 schema:affiliation grid-institutes:grid.267309.9
166 schema:familyName Patel
167 schema:givenName Sunny K.
168 rdf:type schema:Person
169 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
170 schema:name Medical and Health Sciences
171 rdf:type schema:DefinedTerm
172 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
173 schema:name Pharmacology and Pharmaceutical Sciences
174 rdf:type schema:DefinedTerm
175 sg:grant.2408119 http://pending.schema.org/fundedItem sg:pub.10.1007/s00213-012-2870-2
176 rdf:type schema:MonetaryGrant
177 sg:grant.2483189 http://pending.schema.org/fundedItem sg:pub.10.1007/s00213-012-2870-2
178 rdf:type schema:MonetaryGrant
179 sg:grant.2724545 http://pending.schema.org/fundedItem sg:pub.10.1007/s00213-012-2870-2
180 rdf:type schema:MonetaryGrant
181 sg:journal.1085440 schema:issn 0033-3158
182 1432-2072
183 schema:name Psychopharmacology
184 schema:publisher Springer Nature
185 rdf:type schema:Periodical
186 sg:person.01324156236.77 schema:affiliation grid-institutes:grid.273335.3
187 schema:familyName Li
188 schema:givenName Jun-Xu
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324156236.77
190 rdf:type schema:Person
191 sg:person.01365667754.78 schema:affiliation grid-institutes:grid.267309.9
192 schema:familyName Shah
193 schema:givenName Aparna P.
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365667754.78
195 rdf:type schema:Person
196 sg:person.0651327113.82 schema:affiliation grid-institutes:grid.267309.9
197 schema:familyName France
198 schema:givenName Charles P.
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651327113.82
200 rdf:type schema:Person
201 sg:person.0653222230.72 schema:affiliation grid-institutes:grid.94365.3d
202 schema:familyName Rice
203 schema:givenName Kenner C.
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653222230.72
205 rdf:type schema:Person
206 sg:pub.10.1007/bf00435276 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023910507
207 https://doi.org/10.1007/bf00435276
208 rdf:type schema:CreativeWork
209 sg:pub.10.1007/s00210-005-1036-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009091746
210 https://doi.org/10.1007/s00210-005-1036-8
211 rdf:type schema:CreativeWork
212 sg:pub.10.1007/s00213-006-0490-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046544890
213 https://doi.org/10.1007/s00213-006-0490-4
214 rdf:type schema:CreativeWork
215 sg:pub.10.1007/s002130000374 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021502037
216 https://doi.org/10.1007/s002130000374
217 rdf:type schema:CreativeWork
218 sg:pub.10.1007/s002130050490 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029185836
219 https://doi.org/10.1007/s002130050490
220 rdf:type schema:CreativeWork
221 sg:pub.10.1038/npp.2010.232 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004824333
222 https://doi.org/10.1038/npp.2010.232
223 rdf:type schema:CreativeWork
224 grid-institutes:grid.267309.9 schema:alternateName Department of Pharmacology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, 78229-3900, San Antonio, TX, USA
225 Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
226 schema:name Department of Pharmacology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, 78229-3900, San Antonio, TX, USA
227 Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
228 rdf:type schema:Organization
229 grid-institutes:grid.273335.3 schema:alternateName Department of Pharmacology and Toxicology, University at Buffalo, The State University of New York, Buffalo, NY, USA
230 schema:name Department of Pharmacology and Toxicology, University at Buffalo, The State University of New York, Buffalo, NY, USA
231 Department of Pharmacology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, 78229-3900, San Antonio, TX, USA
232 rdf:type schema:Organization
233 grid-institutes:grid.94365.3d schema:alternateName Chemical Biology Research Laboratory, Department of Health and Human Services, National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health (NIH), Bethesda, MD, USA
234 schema:name Chemical Biology Research Laboratory, Department of Health and Human Services, National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health (NIH), Bethesda, MD, USA
235 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...